The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
How To Stop Nausea From Mounjaro — Managing This Common Side Effect
Nausea is one of the most commonly reported side effects when starting Mounjaro (tirzepatide), affecting more than 1 in 10 people. While it's usually temporary and tends to improve as your body adjusts, there are practical steps you can take to manage it. This guide explains what causes nausea with Mounjaro, proven management strategies, and how Mounjaro's nausea profile compares to Wegovy (semaglutide) based on clinical trial data. Whether you're considering starting treatment or already using a GLP-1 medication, understanding how to minimise nausea can help you stay on your treatment plan.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Why Mounjaro Causes Nausea and How It Compares to Wegovy
Nausea occurs because Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist — it activates two hormone pathways that slow how quickly food leaves your stomach and signal fullness to your brain. This mechanism is highly effective for weight management but can trigger nausea, especially during dose increases. Wegovy (semaglutide) works through GLP-1 activation only, which may result in a slightly lower nausea rate in clinical trials, though individual experience varies significantly.
In the SURMOUNT clinical trial for Mounjaro, nausea was reported by approximately 25–30% of participants, typically resolving within 2–4 weeks at each dose level. In the STEP trial for Wegovy, nausea affected approximately 25% of participants. The difference is modest — both medications can cause nausea — but some people report slightly less nausea with Wegovy's single-mechanism approach. However, individual responses vary considerably; some people tolerate Mounjaro well whilst others find Wegovy suits them better. Your prescriber will assess which is more appropriate for your circumstances.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Practical Strategies To Reduce and Manage Nausea on Mounjaro or Wegovy
Slow dose titration: Starting with a low dose (2.5 mg for Mounjaro, 0.25 mg for Wegovy) and waiting at least 4 weeks before increasing allows your body to adjust. Nausea typically peaks in the first week of a new dose then improves.
- Eat small, frequent meals rather than large ones — your stomach empties more slowly on these medications
- Avoid fatty, greasy, or spicy foods, which trigger nausea more easily
- Stay hydrated — sip water regularly throughout the day
- Ginger tea or ginger supplements may help some people reduce nausea naturally
- Avoid alcohol, which worsens nausea
- Take your injection at the same time each week to maintain consistency
- Discuss persistent nausea with your prescriber — they can recommend anti-nausea medication or adjust your dosing schedule
If nausea is severe or doesn't improve after 2–3 weeks at your current dose, contact your GP or the service managing your prescription. Switching between GLP-1 medications or pausing treatment may be options worth exploring.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Which causes worse nausea, Mounjaro or Wegovy?
Clinical trials show similar nausea rates (approximately 25–30% for both), but individual responses differ. Mounjaro's dual mechanism may cause slightly more nausea during dose escalation for some people, whilst others tolerate it well. Your prescriber can help decide which suits you best based on your personal health profile.
How long does nausea last when starting Mounjaro?
Nausea typically appears within the first few days of a new dose and usually improves within 1–2 weeks as your body adjusts. Some people experience mild nausea throughout their first month, then it resolves completely. If nausea persists beyond 3–4 weeks, discuss this with your prescriber.
Can I take anti-nausea medication alongside Mounjaro?
Yes. Common anti-nausea medications like ondansetron (Zofran) or metoclopramide can be prescribed by your GP to help manage nausea whilst you adjust to Mounjaro. Always inform your prescriber that you're taking a GLP-1 medication, as some anti-nausea drugs interact with these treatments.
Is nausea worse during dose increases with tirzepatide?
Yes. Nausea often peaks during the first week of a dose increase, especially when stepping from one Mounjaro KwikPen dose to the next every 4 weeks. This is temporary — waiting the full 4 weeks between dose escalations and managing diet carefully can significantly reduce this effect.
Should I stop Mounjaro if nausea is severe?
Severe nausea lasting more than 2–3 weeks should always be discussed with your GP or the service managing your prescription. Don't stop your treatment without guidance — your prescriber may recommend a slower dose escalation, a switch to another GLP-1 medication, temporary anti-nausea support, or pausing treatment briefly. Never self-manage prescription medication changes.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.